Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Kronos Bio, Inc.
  6. Financials
    KRON   US50107A1043

KRONOS BIO, INC.

(KRON)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 1 674766191--
Enterprise Value (EV)1 1 45860111820051,9
P/E ratio -5,50x-4,92x-1,18x-1,04x-0,81x
Yield -----
Capitalization / Revenue ----51,5x
EV / Revenue ----14,0x
EV / EBITDA -25,5x-4,02x-0,71x-0,92x-0,20x
Price to Book -----
Nbr of stocks (in thousands) 56 03456 34756 732--
Reference price (USD) 29,913,63,363,363,36
Announcement Date 03/23/202102/24/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 -----3,70
EBITDA1 --57,2-149-167-216-260
Operating profit (EBIT)1 -16,8-58,0-151-161-192-260
Operating Margin ------7 032%
Pre-Tax Profit (EBT)1 --88,4-151-160-192-260
Net income1 --88,4-151-155-186-228
Net margin ------6 170%
EPS2 -3,22-5,43-2,76-2,86-3,24-4,16
Dividend per Share ------
Announcement Date 07/31/202003/23/202102/24/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 ------
EBITDA ------
Operating profit (EBIT)1 -33,7-62,4-36,4-39,0-41,6-43,4
Operating Margin ------
Pre-Tax Profit (EBT)1 -33,6-62,3-36,3-37,7-39,0-40,9
Net income1 -33,6-62,3-36,3-37,9-40,5-44,4
Net margin ------
EPS2 -0,61-1,13-0,65-0,70-0,74-0,77
Dividend per Share ------
Announcement Date 11/09/202102/24/202205/04/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2020 2021 2022 2023 2024
Net Debt1 ---9,26-
Net Cash position1 21616573,0-139
Leverage (Debt / EBITDA) 3,78x1,10x0,44x-0,04x0,53x
Free Cash Flow1 -47,5-122-147-193-241
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share -----
Cash Flow per Share -----
Capex1 9,574,266,007,008,00
Capex / Sales ----216%
Announcement Date 03/23/202102/24/2022---
1 USD in Million
Estimates
Key data
Capitalization (USD) 190 620 195
Number of employees 96
Free-Float 85,5%
Free-Float capitalization (USD) 162 994 322
Avg. Exchange 20 sessions (USD) 2 367 889
Average Daily Capital Traded 1,24%
EPS & Dividend